company background image
688363 logo

Bloomage BioTechnology SHSE:688363 Stock Report

Last Price

CN¥60.82

Market Cap

CN¥29.0b

7D

-6.8%

1Y

-20.0%

Updated

20 Nov, 2024

Data

Company Financials +

Bloomage BioTechnology Corporation Limited

SHSE:688363 Stock Report

Market Cap: CN¥29.0b

688363 Stock Overview

Bloomage BioTechnology Corporation Limited researchers, develops, produces, and sells bioactive materials. More details

688363 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth4/6
Past Performance2/6
Financial Health6/6
Dividends2/6

Bloomage BioTechnology Corporation Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Bloomage BioTechnology
Historical stock prices
Current Share PriceCN¥60.82
52 Week HighCN¥84.59
52 Week LowCN¥44.72
Beta0.87
11 Month Change-0.46%
3 Month Change13.87%
1 Year Change-19.98%
33 Year Change-64.18%
5 Year Change-26.25%
Change since IPO-28.53%

Recent News & Updates

Why Bloomage BioTechnology's (SHSE:688363) Shaky Earnings Are Just The Beginning Of Its Problems

Nov 06
Why Bloomage BioTechnology's (SHSE:688363) Shaky Earnings Are Just The Beginning Of Its Problems

After Leaping 40% Bloomage BioTechnology Corporation Limited (SHSE:688363) Shares Are Not Flying Under The Radar

Sep 30
After Leaping 40% Bloomage BioTechnology Corporation Limited (SHSE:688363) Shares Are Not Flying Under The Radar

Recent updates

Why Bloomage BioTechnology's (SHSE:688363) Shaky Earnings Are Just The Beginning Of Its Problems

Nov 06
Why Bloomage BioTechnology's (SHSE:688363) Shaky Earnings Are Just The Beginning Of Its Problems

After Leaping 40% Bloomage BioTechnology Corporation Limited (SHSE:688363) Shares Are Not Flying Under The Radar

Sep 30
After Leaping 40% Bloomage BioTechnology Corporation Limited (SHSE:688363) Shares Are Not Flying Under The Radar

Need To Know: Analysts Just Made A Substantial Cut To Their Bloomage BioTechnology Corporation Limited (SHSE:688363) Estimates

Aug 30
Need To Know: Analysts Just Made A Substantial Cut To Their Bloomage BioTechnology Corporation Limited (SHSE:688363) Estimates

Bloomage BioTechnology Corporation Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Aug 27
Bloomage BioTechnology Corporation Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Bloomage BioTechnology (SHSE:688363) Seems To Use Debt Quite Sensibly

Jun 02
Bloomage BioTechnology (SHSE:688363) Seems To Use Debt Quite Sensibly

Weak Statutory Earnings May Not Tell The Whole Story For Bloomage BioTechnology (SHSE:688363)

May 06
Weak Statutory Earnings May Not Tell The Whole Story For Bloomage BioTechnology (SHSE:688363)

Getting In Cheap On Bloomage BioTechnology Corporation Limited (SHSE:688363) Might Be Difficult

May 01
Getting In Cheap On Bloomage BioTechnology Corporation Limited (SHSE:688363) Might Be Difficult

Shareholder Returns

688363CN BiotechsCN Market
7D-6.8%-6.3%-4.1%
1Y-20.0%-18.6%3.8%

Return vs Industry: 688363 underperformed the CN Biotechs industry which returned -18.6% over the past year.

Return vs Market: 688363 underperformed the CN Market which returned 3.8% over the past year.

Price Volatility

Is 688363's price volatile compared to industry and market?
688363 volatility
688363 Average Weekly Movement11.0%
Biotechs Industry Average Movement8.8%
Market Average Movement8.2%
10% most volatile stocks in CN Market12.6%
10% least volatile stocks in CN Market5.6%

Stable Share Price: 688363's share price has been volatile over the past 3 months compared to the CN market.

Volatility Over Time: 688363's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of CN stocks.

About the Company

FoundedEmployeesCEOWebsite
20004,417Yan Zhaowww.bloomagebioactive.com

Bloomage BioTechnology Corporation Limited researchers, develops, produces, and sells bioactive materials. It offers pharmaceutical grade sodium hyaluronate which can be used as an API or excipient for drugs and medical devices in ophthalmic preparations, intra-articular injections, anti-adhesive preparations, and topical preparations for wound healing and soft tissue filler under the Hyature name; and cosmetic grade sodium hyaluronate solutions for cosmetic products, including moisturizing, repairing, delay skin aging, and brightening under the Hybloom, miniHA, microHA, Hyacross, Hyacolor, and cationHA. The company also provides food-grade sodium hyaluronate for use in food/healthy food/dietary supplements under the HAPLEX name, as well as food-grade gamma aminobutyric acid under the Gabarelax name; hyaluronic acid for oral care under the Biomoist name; and animal care products under the HYAPET names.

Bloomage BioTechnology Corporation Limited Fundamentals Summary

How do Bloomage BioTechnology's earnings and revenue compare to its market cap?
688363 fundamental statistics
Market capCN¥29.03b
Earnings (TTM)CN¥440.18m
Revenue (TTM)CN¥5.73b

66.1x

P/E Ratio

5.1x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
688363 income statement (TTM)
RevenueCN¥5.73b
Cost of RevenueCN¥1.53b
Gross ProfitCN¥4.20b
Other ExpensesCN¥3.76b
EarningsCN¥440.18m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)0.92
Gross Margin73.25%
Net Profit Margin7.68%
Debt/Equity Ratio1.8%

How did 688363 perform over the long term?

See historical performance and comparison

Dividends

0.6%

Current Dividend Yield

42%

Payout Ratio